Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2492-2499

  Leaños Miranda, Alfredo ^a,b   Márquez Acosta, Janeth ^a   Cárdenas Mondragón, Guadalupe María ^a   Chinolla Arellano, Zarela Lizbeth ^a   Rivera Leaños, Roxana ^a   Bermejo Huerta, Sara ^a   Romero Arauz, Juan Fernando ^a   Alvarez Jiménez, Guadalupe ^a   Ramos León, Julio César ^a   Ulloa Aguirre, Alfredo ^a  

^a Hospital Luis Castelazo Ayala   (Mexico)

^b Research Unit in Reproductive Medicine   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; LIVER ENZYME; PROLACTIN;

ABNORMAL URINE COMPOSITION; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HEMOLYSIS; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINURIA; PROTEINURIA; SOLUTIO PLACENTAE; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

EID: 47549096067     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0305     Document Type: Article

References (37)

1. Roberts JM 1998 Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16:5-15
2. Chesley LC 1985 Diagnosis of preeclampsia. Obstet Gynecol 65:423-425
3. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. 2000 Am J Obstet Gynecol 183:S1-S22
4. Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, Catalano PM, Morris CD 2000 Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 95:24-28
5. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA 2003 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658
6. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF 2004 Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683
7. Kendall RL, Thomas KA 1993 Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90:10705-10709
8. He Y, Smith SK, Day KA, Clark DE, Licence DR, Charnock-Jones DS 1999 Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 13:537-545
9. Ferrara N 2001 Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280:C1358-C1366
10. Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O, Taketani Y 2003 Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 88:2348-2351
11. Buhimschi CS, Norwitz ER, Funai E, Richman S, Guller S, Lockwood CJ, Buhimschi IA 2005 Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol 192:734-741
12. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA; CPEP Study Group 2006 Soluble endoglin and other circulating antiangiogenic factor in preeclampsia. N Engl J Med 355:992-1005
13. Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA 2005 Urinary placental growth factor and risk of preeclampsia. JAMA 293:77-85
14. Struman I, Bentzien F, Lee HY, Mainfroid V, D'Angelo G, Goffin V, Weiner RI, Martial JA 1999 Opposing actions of intact and N-terminal fragments of the human prolactin growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 96:1246-1251
15. Freeman ME, Kanyicska B, Lerant A, Nagy G 2000 Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1253-1631
16. Sinha YN 1995 Structural variants of prolactin: occurrence and physiological significance. Endocr Rev 16:354-364
17. Pascoe-Lira D, Duran-Reyes G, Contreras-Hernández I, Manuel-Apolinar L, Blanco-Favela F, Leaños-Miranda A 2001 Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women. J Clin Endocrinol Metab 86:924-929
18. Corbacho AM, Martínez De La Escalera G, Clapp C 2002 Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. J Endocrinol 173:219-238
19. Clapp C, Martial JA, Guzman RC, Rentier-Delrue F, Weiner RI 1993 The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292-1299
20. Clapp C, Torner L, Gutiérrez-Ospina G, Alcántara E, López-Gómez FJ, Nagano M, Kelly PA, Mejía S, Morales MA, Martínez de la Escalera G 1994 The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin. Proc Natl Acad Sci USA 91:10384-10388
21. ACOG Committee on Practice Bulletins-Obstetrics 2002 ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 99:159-167
22. Leaños-Miranda A, Márquez-Acosta J, Romero-Arauz F, Cárdenas-Mondragón MG, Rivera-Leaños R, Isordia-Salas I, Ulloa-Aguirre A 2007 Protein: creatinine ratio in random urine samples is a reliable marker of increased 24-hour protein excretion in hospitalized women with hypertensive disorders of pregnancy. Clin Chem 53:1623-1628
23. Zhang J, Bowes Jr WA 1995 Birth-weight-for-gestational-age patterns by race, sex, and parity in the United States population. Obstet Gynecol 86:200-208
24. Leaños-Miranda A, Contreras-Hernandez I 2002 Antiprolactin autoantibodies are associated with hyperprolactinemia status in men infected with human immunodeficiency virus. Endocrine 19:139-146
25. Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda K, Blanco-Favela F 2001 Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus. J Clin Endocrinol Metab 86:2619-2624
26. Gala RR, Singhakowinta A, Brennan MJ 1975 Studies on prolactin in human serum, urine and milk. Horm Res 6:310-320
27. Keely EJ, Faiman C 1994 Measurement of human urinary prolactin as a noninvasive study tool. Clin Chem 40(11 Pt 1):2017-2021
28. González C, Parra A, Ramírez-Peredo J, García C, Rivera JC, Macotela Y, Aranda J, Lemini M, Arias J, Ibargüengoitia F, de la Escalera GM, Clapp C 2007 Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia. Lab Invest 87:1009-1017
29. Ferrara N, Clapp C, Weiner R 1991 The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129:896-900
30. Clapp C 1987 Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat: characterization of the cleaved and 16K forms. Endocrinology 121:2055-2064
31. Baldocchi RA, Tan L, King DS, Nicoll CS 1993 Mass spectrometric analysis of the fragments produced by cleavage and reduction of rat prolactin: evidence that the cleaving enzyme is cathepsin D. Endocrinology 133:935-938
32. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H 2007 A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589-600
33. Piwnika D, Fernandez I, Binart N, Touraine P, Kelly PA, Goffin V 2006 A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D. Mol Endocrinol 20:3263-3278
34. Chen BL, Zhang ZH, Liu NB, Huang KS 2001 [Prolactin in normal pregnancy and severe pregnancy-induced hypertension]. Hunan Yi Ke Da Xue Xue Bao 26:67-69 (Chinese)
35. Luciano AA, Varner MW 1984 Decidual, amniotic fluid, maternal and fetal prolactin in normal and abnormal pregnancies. Obstet Gynecol 63:384-388
36. Miyakawa I, Taniyama K, Sakata M, Yamaguchi M, Mori N 1986 Prolactin in severe toxemia of pregnancy. Eur J Obstet Gynecol Reprod Biol 23:25-30
37. Ranta T, Stenman UH, Unnérus HA, Rossi J, Sépala M 1980 Maternal plasma prolactin levels in preeclampsia. Obstet Gynecol 55:428-430